Ben Tran
The University of Melbourne · 113 works · 9,276 citations · h-index 22
Top works
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
- Cancer Genomics: Technology, Discovery, and Translation
- Survival comparison between glioblastoma multiforme and other incurable cancers
- Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial
- Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
- Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
- Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer
- The rapidly escalating cost of treating colorectal cancer in A ustralia
- Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival
- Phase III RECOURSE trial of TAS-102 versus placebo with best supportive care in patients with metastatic colorectal cancer: Geographic subgroups.
- Serial circulating tumor DNA (ctDNA) and recurrence risk in patients (pts) with resectable colorectal liver metastasis (CLM).
- Treatment and outcomes of metastatic colorectal cancer in A ustralia: defining differences between public and private practice
- Can systemic inflammation at diagnosis predict benefit from primary resection in metastatic colorectal cancer (mCRC)?
- Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities
- A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours